IBB PAS Repository

Extracellular vesicles of Janthinobacterium lividum as violacein carriers in melanoma cell treatment

Kowalska, Patrycja and Mierzejewska, Jolanta and Skrzeszewska, Paulina and Witkowska, Aleksandra and Oksejuk, Katarzyna and Sitkiewicz, Ewa and Krawczyk, Mariusz and Świadek, Magdalena and Głuchowska, Agata and Marlicka, Klaudia and Sobiepanek, Anna and Milner-Krawczyk, Małgorzata (2024) Extracellular vesicles of Janthinobacterium lividum as violacein carriers in melanoma cell treatment. Applied Microbiology and Biotechnology, 108 (529). ISSN 0175-7598

[img]
Preview
PDF
1MB

Official URL: https://link.springer.com/article/10.1007/s00253-0...

Abstract

Violacein is a natural indole-derived purple pigment of microbial origin that has attracted attention for its remarkable biological properties. Due to its poor solubility in aqueous media, most studies of this pigment use extracts of the compound obtained with common solvents. Violacein is also transported in bacterial extracellular vesicles (EVs) and transferred via this type of carrier remains stable in an aqueous environment. This paper is the first to present an in-depth study of Janthinobacterium lividum EVs as violacein carriers. J. lividum EVs were studied for their contribution to violacein translocation, size, morphology and protein composition. The production of violacein encapsulated in EVs was more efficient than the intracellular production of this compound. The average size of the violacein-containing EVs was 124.07±3.74 nm. Liquid chromatography-tandem mass spectrometry analysis (LC-MS/MS) revealed 932 proteins common to three independent EVs isolations. The high1 proportion of proteins with intracellular localisation, which are involved in many fundamental cellular processes, suggests that J. lividum EVs could be generated in a cell lysis model, additionally stimulated by violacein production. Using human keratinocytes and melanoma cell lines, it was confirmed that J. lividum EVs are able to react with and deliver their cargo to mammalian cells. The EVs-delivered violacein was shown to retain its activity against melanoma cells, and the dose and timing of treatment can be selected to target only cancer cells. The characterisation of J. lividum EVs, described in the following paper, represents a milestone for their future potential anti-cancer application

Item Type:Article
Subjects:Q Science > Q Science (General)
ID Code:2507
Deposited By: dr Ewa Sitkiewicz
Deposited On:14 Jan 2025 20:24
Last Modified:14 Jan 2025 20:24

Repository Staff Only: item control page